类风湿性关节炎继发骨质疏松症患者的生命质量调查及慢性病管理

发布时间：2018-12-12 21:44

【摘要】：目的调查类风湿性关节炎继发骨质疏松症患者的生命质量,及考察采用慢性病管理的干预效果。方法纳入2013年8月至2016年2月我院风湿科治疗的类风湿性关节炎继发骨质疏松症患者158例作为研究对象。随机分为对照组76例与观察组76例。对照组予常规抗骨质疏松治疗,观察组在常规抗骨质疏松治疗基础上予慢性病管理。通过比较两组患者的类风湿性关节炎的类风湿因子血沉、C反应蛋白以及1年后复查骨密度情况。采用满意度调查以及视觉模拟评分法(VAS)评价患者慢性病管理质量及疼痛情况。结果干预前,两组骨质疏松及类风湿性关节炎观察指标无统计学差异性(P0.05);观察组干预后指标明显优于对照组;1年后复查骨密度,对照组骨质疏松患者明显多于观察组(P0.05)。干预后,观察组患者疼痛评分明显低于对照组(P0.05),观察组患者的慢性病管理效果优于对照组(P0.05)。结论应用慢性病管理模式干预类风湿性关节炎继发骨质疏松症患者后,能有效减少关节疼痛,改善骨质疏松及类风湿性关节炎各项指标值,提高了患者的整体生命质量,值得临床广泛推广。
[Abstract]:Objective to investigate the quality of life (QOL) of patients with secondary osteoporosis of rheumatoid arthritis (RA) and the intervention effect of chronic disease management. Methods 158 cases of osteoporosis secondary to rheumatoid arthritis treated by rheumatoid arthritis in our hospital from August 2013 to February 2016 were included. They were randomly divided into control group (76 cases) and observation group (76 cases). The control group was treated with routine anti-osteoporosis and the observation group was treated with chronic disease on the basis of routine anti-osteoporosis treatment. Rheumatoid factor ESR, C-reactive protein (CRP) and bone mineral density (BMD) of rheumatoid arthritis (RA) were compared between the two groups. Satisfaction survey and visual analogue score (VAS) were used to evaluate the quality of chronic disease management and pain. Results before intervention, there was no significant difference in the indexes of osteoporosis and rheumatoid arthritis between the two groups (P0.05), and the indexes of the observation group after intervention were significantly better than those of the control group. One year later, the bone mineral density in the control group was significantly higher than that in the observation group (P 0.05). After intervention, the pain score of the patients in the observation group was significantly lower than that in the control group (P0.05), and the effect of chronic disease management in the observation group was better than that in the control group (P0.05). Conclusion the application of chronic disease management model in patients with secondary osteoporosis of rheumatoid arthritis can effectively reduce joint pain, improve the index values of osteoporosis and rheumatoid arthritis, and improve the overall quality of life of the patients. It is worth popularizing widely in clinic.
【作者单位】：惠州市中心人民医院;
【分类号】：R580;R593.22

【相似文献】